| 2023-04-27 |
详情>>
内部人交易：
Points Jeffrey S.等共交易15笔
|
| 2023-03-23 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 8, 2023 (such agreement, as it may be amended, modified or supplemented from time to time, the “Merger Agreement”), by and among CSI, Abbott Laboratories, an Illinois corporation (“Abbott”), and Cobra Acquisition Co., a Delaware corporation (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, Abbott will acquire CSI via a merger of Merger Sub with and into CSI, with the separate corporate existence of Merger Sub thereupon ceasing and CSI continuing as the surviving corporation and a wholly-owned subsidiary of Abbott (the “Merger”);
2.To consider and vote on the proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to CSI’s named executive officers that is based on or otherwise relates to the Merger Agreement, the Merger, and the other transactions contemplated by the Merger Agreement (the “Compensation Proposal”);
3.To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2023-03-23 |
详情>>
股本变动：
变动后总股本4219.80万股
|
| 2023-02-09 |
复牌提示：
2023-02-08 18:02:48 停牌，复牌日期 2023-02-08 18:35:00
|
| 2023-02-09 |
详情>>
业绩披露：
2023年中报每股收益-0.47美元,归母净利润-1851.9万美元,同比去年增长-5.31%
|
| 2023-02-09 |
财报披露：
美东时间 2023-02-09 盘前发布财报
|
| 2022-11-03 |
详情>>
业绩披露：
2023年一季报每股收益-0.27美元,归母净利润-1063.1万美元,同比去年增长-23.36%
|
| 2022-09-28 |
股东大会：
将于2022-11-08召开股东大会
会议内容 ▼▲
- 1.To elect as Class II directors to hold office until the fiscal 2025 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Scott R. Ward and Kelvin Womack.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2023.
3.To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2022-08-18 |
详情>>
业绩披露：
2020年年报每股收益-0.79美元,归母净利润-2723.6万美元,同比去年增长-10580.78%
|
| 2022-08-18 |
详情>>
业绩披露：
2022年年报每股收益-0.94美元,归母净利润-3693.3万美元,同比去年增长-175.19%
|
| 2022-05-05 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.7美元,归母净利润-2724.3万美元,同比去年增长-234.85%
|
| 2022-02-03 |
详情>>
业绩披露：
2022年中报每股收益-0.45美元,归母净利润-1758.5万美元,同比去年增长-724.81%
|
| 2021-11-09 |
详情>>
业绩披露：
2021年一季报每股收益-0.05美元,归母净利润-207.6万美元,同比去年增长64.08%
|
| 2021-11-09 |
详情>>
业绩披露：
2022年一季报每股收益-0.22美元,归母净利润-861.8万美元,同比去年增长-315.13%
|
| 2021-09-29 |
股东大会：
将于2021-11-11召开股东大会
会议内容 ▼▲
- 1.To elect as Class I directors to hold office until the fiscal 2024 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Augustine Lawlor and Erik Paulsen.
2.To approve a 1,700,000 share increase to the number of shares of the Company’s common stock available for issuance under the Amended and Restated 2017 Equity Incentive Plan.
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2022.
4.To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
5.To conduct any other business properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-19 |
详情>>
业绩披露：
2021年年报每股收益-0.35美元,归母净利润-1342.1万美元,同比去年增长50.72%
|
| 2021-05-06 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.21美元,归母净利润-813.6万美元,同比去年增长32.59%
|
| 2021-02-04 |
详情>>
业绩披露：
2021年中报每股收益-0.06美元,归母净利润-213.2万美元,同比去年增长76.78%
|
| 2020-09-29 |
股东大会：
将于2020-11-11召开股东大会
会议内容 ▼▲
- 1.To elect as Class III directors to hold office until the fiscal 2023 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Martha Goldberg Aronson, William Cohn, M.D. and Stephen Stenbeck.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2021.
3.To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2019-10-01 |
股东大会：
将于2019-11-13召开股东大会
会议内容 ▼▲
- 1.To elect as a Class II director to hold office until the fiscal 2022 Annual Meeting of Stockholders, the following nominee recommended by the Board of Directors: Scott R. Ward.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2020.
3.To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2018-10-02 |
股东大会：
将于2018-11-14召开股东大会
会议内容 ▼▲
- 1.To elect as Class I directors to hold office until the fiscal 2021 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Scott Bartos, Edward Brown, and Augustine Lawlor.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2019.
3.To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
4.To conduct any other business properly brought before the meeting.
|
| 2017-10-03 |
股东大会：
将于2017-11-15召开股东大会
会议内容 ▼▲
- 1. To elect as Class III directors to hold office until the fiscal 2020 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Martha Goldberg Aronson and William E. Cohn, M.D.
2. To approve the 2017 Equity Incentive Plan.
3. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2018.
4. To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
5. To determine, on an advisory basis, whether the preferred frequency of the stockholder advisory vote on the executive compensation of the Company’s named executive officers as set forth in the Company’s proxy statement should be every year, every two years or every three years.
6. To conduct any other business properly brought before the meeting.
|
| 2016-10-04 |
股东大会：
将于2016-11-16召开股东大会
会议内容 ▼▲
- 1. To elect as Class II directors to hold office until the fiscal 2019 Annual Meeting of Stockholders, the following nominees recommended by the Board of Directors: Brent G. Blackey, Leslie L. Trigg and Scott R. Ward.
2. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2017.
3. To approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers.
4. To conduct any other business properly brought before the meeting.
|